Australia Diabetes Devices Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The Australia diabetes devices market covers equipment used to diagnose, monitor, and manage diabetes, including blood glucose meters, test strips, continuous glucose monitoring systems, insulin pumps, and insulin pens. In 2025, the market is valued at approximately $721 million, with projections reaching roughly $833 million by 2031 at a 2.43% CAGR. Australia's high burden of diabetes, affecting millions and costing the healthcare system billions annually in direct and indirect costs, underpins sustained demand across all device categories.

• •Market valued at ~$721 million in 2025, projected to reach ~$833 million by 2031 at 2.43% CAGR
• •Spans blood glucose monitors, continuous glucose monitoring systems, insulin pumps, pens, and digital management platforms
• •Government health data agencies report diabetes prevalence and healthcare expenditure, but commercial market-size figures come from private analysts

Australia's adult diabetes prevalence has been steadily increasing, driven by rising obesity rates, sedentary lifestyles, and a growing proportion of older adults, all established risk factors for Type 2 diabetes, which accounts for the vast majority of cases. Government-funded subsidy schemes, notably the National Diabetes Services Scheme, reduce patient out-of-pocket costs and drive uptake of both conventional and next-generation devices. The transition from episodic self-monitoring of blood glucose to continuous monitoring, combined with digital health integration, is accelerating demand for more advanced products.

• •Rising Type 2 diabetes prevalence linked to aging demographics, obesity, and lifestyle factors
• •National Diabetes Services Scheme and other government programs subsidize device costs, expanding access and adoption
• •Shift toward continuous glucose monitoring and digital management platforms driving faster growth in those segments than the overall market

The market is broadly segmented into blood glucose monitoring devices (traditional meters and test strips) and insulin delivery systems (pumps and pens), with continuous glucose monitoring emerging as the fastest-growing sub-segment, expected to expand at over 12.7% CAGR. Digital diabetes management platforms, encompassing apps, connected devices, and remote monitoring software, represent a higher-growth niche projected at 9.8% to 16% CAGR depending on the analysis. Geographically, the market is concentrated in major urban centers along Australia's eastern seaboard, where population density and healthcare infrastructure are strongest.

• •Continuous glucose monitoring segment projected to grow at over 12.7% CAGR, outpacing conventional blood glucose monitoring
• •Digital diabetes management market in Australia projected at 9.8% to 16% CAGR depending on scope and methodology
• •Blood glucose monitoring market alone estimated at ~$278 million in 2023, projected to reach ~$633 million by 2033

What are the recent trends and outlook?

The market is moving strongly toward integrated, connected diabetes management ecosystems that combine hardware sensors with software platforms, enabling real-time data sharing between patients and healthcare providers. Integration with artificial intelligence for predictive glucose trend analysis and automated insulin dosing is expected to deepen over the coming years. Regulatory pathways for device approvals and reimbursement negotiations with Australia's Pharmaceutical Benefits Advisory Committee will be critical factors shaping market access and adoption rates through the early 2030s.

• •Growing integration of AI and connected platforms enabling remote monitoring and predictive analytics for glucose management
• •Regulatory and reimbursement decisions through the PBAC will significantly influence market access for new device launches
• •Overall diabetes care devices market globally projected to reach ~$61.2 billion by 2030, with Australia representing a mature but innovation-driven sub-market